
Last update at 2024-09-26T03:06:13.231453Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown |
|---|
| Breakdown |
|---|
| Breakdown |
|---|
Sector: Healthcare Industry: Diagnostics & Research
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | ||
|---|---|---|---|---|---|---|---|---|
| AMCY ACS Global Inc |
- -% | - | - | - | - | - | ||
| TMO Thermo Fisher Scientific Inc |
-0.6 0.13% | 464.01 | 34.71 | 23.87 | 4.62 | 4.43 | 5.29 | 20.89 |
| DHR Danaher Corporation |
1.02 0.58% | 178.19 | 29.09 | 28.01 | 5.67 | 3.20 | 6.00 | 19.09 |
| A Agilent Technologies Inc |
-0.57 0.45% | 126.49 | 34.36 | 26.39 | 6.59 | 7.14 | 6.78 | 23.56 |
| IDXX IDEXX Laboratories Inc |
-16.36 2.91% | 545.73 | 49.99 | 45.66 | 11.29 | 27.85 | 11.46 | 34.46 |
ACS Global, Inc. engages in the collection, processing, and long-term storage of stem cells. The company's services would allow individuals to privately preserve their stem cells for potential future use in cell therapy. The company was formerly known as American CryoStem Corp. and changed its name to ACS Global, Inc. in June 2011. The company is based in Red Bank, New Jersey.
188 East Bergen Place, Red Bank, NJ, United States, 07701
| Name | Title | Year Born |
|---|---|---|
| Mr. Anthony Francis Dudzinski Jr. | Pres, Director & Treasurer | 1963 |
| Mr. John S. Arnone | Director & Sec. | 1958 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.